Satish kumar Yadav,
Mohd. Wasiullah,
Piyush Yadav,
Safiya Sajid,
Ms. Anjali Maurya,
- Associate professor, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Principal ,Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Academic Head, Department Of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Research Scholar, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Lecturer, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
Abstract
A comprehensive review of the use of computer-aided drug design (CADD) in the creation of innovative neurologic and neuropsychiatric medications is given in this article. It discusses the challenges in traditional drug discovery approaches and highlights the role of computational methods in accelerating the identification and optimization of drug candidates targeting psychiatric and neurological disorders. The method of finding new drugs has been completely transformed by Computer-Aided Drug Design (CADD), which combines medicinal chemistry concepts with computer tools. This review explores the applications of CADD in the development of psychotropic and neurological drugs. Beginning with an overview of psychotropic and neurological disorders, the article delves into the challenges faced in traditional drug discovery methods. It then elucidates the principles and methodologies of CADD, including molecular docking, pharmacophore modeling, and quantitative structure-activity relationship (QSAR) analysis. Subsequently, case studies highlight successful applications of CADD in the identification and optimization of lead compounds targeting various psychotropic and neurological targets. Finally, the review discusses future prospects and challenges in the field, emphasizing the potential of CADD to expedite the discovery of novel therapeutics for these debilitating disorders.
Keywords: ligand-based drug design; docking; QSAR; pharmacophore; Alzheimer’s disease; structure-based drug design; schizophrenia; neuropathic pain; neurological; deep learning; molecular dynamics; psychotropic; virtual screening; computer-aided drug design; artificial intelligence
[This article belongs to International Journal of Brain Sciences (ijbs)]
Satish kumar Yadav, Mohd. Wasiullah, Piyush Yadav, Safiya Sajid, Ms. Anjali Maurya. An Extensive Analysis of Computer-Aided Drug Design for Novel Psychotropic and Neurological Substances. International Journal of Brain Sciences. 2024; 01(02):15-23.
Satish kumar Yadav, Mohd. Wasiullah, Piyush Yadav, Safiya Sajid, Ms. Anjali Maurya. An Extensive Analysis of Computer-Aided Drug Design for Novel Psychotropic and Neurological Substances. International Journal of Brain Sciences. 2024; 01(02):15-23. Available from: https://journals.stmjournals.com/ijbs/article=2024/view=155690
References
- Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK, Hägg S, Athanasiu L, Voyle N. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nature genetics. 2019 Mar;51(3):404-13.
- Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, Davies G, Ritchie CW, Gale CR, Starr JM, Goate AM. GWAS on family history of Alzheimer’s disease. Translational psychiatry. 2018 May 18;8(1):99.
- Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, Van Der Lee SJ, Amlie-Wolf A, Bellenguez C. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature genetics. 2019 Mar;51(3):414-30.
- De Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I, Montrreal L. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores. Nature communications. 2021 Jun 7;12(1):3417.
- Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, Young AM, Franklin RJ, Johnson T, Estrada K, Gaffney DJ. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nature genetics. 2021 Mar;53(3):392-402.
- Patel T, Brookes KJ, Turton J, Chaudhury S, Guetta‐Baranes T, Guerreiro R, Bras J, Hernandez D, Singleton A, Francis PT, Hardy J. Whole‐exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer’s disease. Neuropathology and applied neurobiology. 2018 Aug;44(5):506-21.
- Raghavan NS, Brickman AM, Andrews H, Manly JJ, Schupf N, Lantigua R, Wolock CJ, Kamalakaran S, Petrovski S, Tosto G, Vardarajan BN. Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer’s disease. Annals of clinical and translational neurology. 2018 Jul;5(7):832-42.
- Chan HS, Li Y, Dahoun T, Vogel H, Yuan S. New binding sites, new opportunities for GPCR drug discovery. Trends in biochemical sciences. 2019 Apr 1;44(4):312-30.
- Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Rongve A, Børte S, Winsvold BS, Drange OK, Martinsen AE, Skogholt AH. Largest GWAS (N= 1,126,563) of Alzheimer’s disease implicates microglia and immune cells. MedRxiv. 2020 Nov 23:2020-11.
- Bellenguez C, Küçükali F, Jansen I, Andrade V, Moreno-Grau S, Amin N, Naj AC, Grenier-Boley B, Campos-Martin R, Holmans PA, Boland A. New insights on the genetic etiology of Alzheimer’s and related dementia. MedRxiv. 2020 Oct 4:2020-10.
- Ray R. Understanding the Structural Importance of the Non-Binding and Binding Parts of Bedaquiline and Its Analogues with ATP Synthase Subunit C Using Molecular Docking, Molecular Dynamics Simulation and 3D-QSAR Techniques. InProceedings of International Conference on Drug Discovery (ICDD) 2020 Feb 19.
- Du M, Qiu Y, Li Q, Li Y. Efficacy coefficient method assisted quadruple-activities 3D-QSAR pharmacophore model for application in environmentally friendly PAE molecular modification. Environmental Science and Pollution Research. 2020 Jul;27:24103-14.
- Kotzabasaki MI, Sotiropoulos I, Sarimveis H. QSAR modeling of the toxicity classification of superparamagnetic iron oxide nanoparticles (SPIONs) in stem-cell monitoring applications: an integrated study from data curation to model development. RSC advances. 2020;10(9):5385-91.
- Zerroug A, Belaidi S, BenBrahim I, Sinha L, Chtita S. Virtual screening in drug-likeness and structure/activity relationship of pyridazine derivatives as Anti-Alzheimer drugs. Journal of King Saud University-Science. 2019 Oct 1;31(4):595-601.
- Ray R. Understanding the Structural Importance of the Non-Binding and Binding Parts of Bedaquiline and Its Analogues with ATP Synthase Subunit C Using Molecular Docking, Molecular Dynamics Simulation and 3D-QSAR Techniques. InProceedings of International Conference on Drug Discovery (ICDD) 2020 Feb 19.
- Morales-Navarro S, Prent-Peñaloza L, Rodríguez Núñez YA, Sánchez-Aros L, Forero-Doria O, González W, Campilllo NE, Reyes-Parada M, Martínez A, Ramírez D. Theoretical and experimental approaches aimed at drug design targeting neurodegenerative diseases. Processes. 2019 Dec 10;7(12):940.
- Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA. Ageing as a risk factor for neurodegenerative disease. Nature Reviews Neurology. 2019 Oct;15(10):565-81.
- Fan F, Toledo Warshaviak D, Hamadeh HK, Dunn RT. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs. PloS one. 2019 Jan 3;14(1):e0204378.
- Espinoza‐Moraga M, Caballero J, Gaube F, Winckler T, Santos LS. 1‐Benzyl‐1, 2, 3, 4‐Tetrahydro‐β‐Carboline as Channel Blocker of N‐Methyl‐d‐Aspartate Receptors. Chemical Biology & Drug Design. 2012 Apr;79(4):594-9.
- Schmiedel JM, Lehner B. Determining protein structures using deep mutagenesis. Nature genetics. 2019 Jul;51(7):1177-86.
- Gbeddy G, Egodawatta P, Goonetilleke A, Ayoko G, Chen L. Application of quantitative structure-activity relationship (QSAR) model in comprehensive human health risk assessment of PAHs, and alkyl-, nitro-, carbonyl-, and hydroxyl-PAHs laden in urban road dust. Journal of hazardous materials. 2020 Feb 5;383:121154.
- Morales-Navarro S, Prent-Peñaloza L, Rodríguez Núñez YA, Sánchez-Aros L, Forero-Doria O, González W, Campilllo NE, Reyes-Parada M, Martínez A, Ramírez D. Theoretical and experimental approaches aimed at drug design targeting neurodegenerative diseases. Processes. 2019 Dec 10;7(12):940.
- Vieira T, Magalhaes R, Sousa S. Tailoring specialized scoring functions for more efficient virtual screening. Frontiers. 2019;2:1-4.
- Makarasen A, Kuno M, Patnin S, Reukngam N, Khlaychan P, Deeyohe S, Intachote P, Saimanee B, Sengsai S, Boonsri P, Chaivisuthangkura A. Molecular docking studies and synthesis of amino-oxy-diarylquinoline derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Drug Research. 2019 Dec;69(12):671-82.
- Wang B, Dai P, Ding D, Del Rosario A, Grant RA, Pentelute BL, Laub MT. Affinity-based capture and identification of protein effectors of the growth regulator ppGpp. Nature chemical biology. 2019 Feb;15(2):141-50.
- Kumar J, Ranjan T, Kumar RR, Ansar M, Rajani K, Kumar M, Kumar V, Kumar A. In silico characterization and homology Modelling of Potato Leaf Roll Virus (PLRV) coat protein. Current Journal of Applied Science and Technology. 2019 Mar 5;33(2):1-8.
Volume | 01 |
Issue | 02 |
Received | 10/05/2024 |
Accepted | 14/05/2024 |
Published | 09/07/2024 |